Cunnah D, Ross G, Besser G M
Clin Endocrinol (Oxf). 1986 Mar;24(3):253-7. doi: 10.1111/j.1365-2265.1986.tb03265.x.
The effect of oral administration of desmopressin (DDAVP) solution was investigated in six patients with cranial diabetes insipidus of varying aetiology. All patients experienced a prompt and prolonged antidiuresis. Nine patients have been managed with oral DDAVP tablets for up to 5 months and all preferred this route of administration to intranasal application using a rhinyle. Oral DDAVP gives excellent and convenient control in cranial diabetes insipidus.
研究了口服去氨加压素（DDAVP）溶液对6例不同病因的颅咽管型尿崩症患者的疗效。所有患者均出现迅速且持久的抗利尿作用。9例患者使用口服DDAVP片治疗长达5个月，所有人都更喜欢这种给药途径，而不是使用滴鼻器经鼻给药。口服DDAVP对颅咽管型尿崩症有极佳且方便的控制效果。
